Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Long-Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients.

Le Joncour A, Soudet S, Dupont A, Espitia O, Koskas F, Cluzel P, Hatron PY, Emmerich J, Cacoub P, Resche-Rigon M, Lambert M, Saadoun D; French Buerger's Network.

J Am Heart Assoc. 2018 Dec 4;7(23):e010677. doi: 10.1161/JAHA.118.010677.

2.

Malignant Meningioma: An International Multicentre Retrospective Study.

Champeaux C, Jecko V, Houston D, Thorne L, Dunn L, Fersht N, Khan AA, Resche-Rigon M.

Neurosurgery. 2018 Dec 19. doi: 10.1093/neuros/nyy610. [Epub ahead of print]

PMID:
30566646
3.

Big data and targeted machine learning in action to assist medical decision in the ICU.

Pirracchio R, Cohen MJ, Malenica I, Cohen J, Chambaz A, Cannesson M, Lee C, Resche-Rigon M, Hubbard A; ACTERREA Research Group.

Anaesth Crit Care Pain Med. 2018 Oct 16. pii: S2352-5568(18)30216-9. doi: 10.1016/j.accpm.2018.09.008. [Epub ahead of print] Review.

PMID:
30339893
4.

Central venous oxygen saturation is not predictive of early complications in cancer patients presenting to the emergency department.

Peyrony O, Dumas G, Legay L, Principe A, Franchitti J, Simonetta M, Verrat A, Amami J, Milacic H, Bragança A, Gillet A, Resche-Rigon M, Fontaine JP, Azoulay E.

Intern Emerg Med. 2018 Oct 10. doi: 10.1007/s11739-018-1966-z. [Epub ahead of print]

PMID:
30306323
5.

Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia.

Contejean A, Resche-Rigon M, Tamburini J, Alcantara M, Jardin F, Lengliné E, Adès L, Bouscary D, Marçais A, Lebon D, Chabrot C, Terriou L, Barraco F, Banos A, Bussot L, Cahn JY, Hirsch P, Maillard N, Simon L, Fornecker LM, Socié G, de Latour RP, de Fontbrune FS.

Haematologica. 2019 Feb;104(2):256-262. doi: 10.3324/haematol.2018.198440. Epub 2018 Sep 27.

6.

Clinical Significance of Upper Airway Virus Detection in Critically Ill Hematology Patients.

Legoff J, Zucman N, Lemiale V, Mokart D, Pène F, Lambert J, Kouatchet A, Demoule A, Vincent F, Nyunga M, Bruneel F, Contejean A, Mercier-Delarue S, Rabbat A, Lebert C, Perez P, Meert AP, Benoit D, Schwebel C, Jourdain M, Darmon M, Resche-Rigon M, Azoulay E.

Am J Respir Crit Care Med. 2019 Feb 15;199(4):518-528. doi: 10.1164/rccm.201804-0681OC.

PMID:
30230909
7.

Heckman imputation models for binary or continuous MNAR outcomes and MAR predictors.

Galimard JE, Chevret S, Curis E, Resche-Rigon M.

BMC Med Res Methodol. 2018 Aug 31;18(1):90. doi: 10.1186/s12874-018-0547-1.

8.

Algorithms to Define Abnormal Growth in Children: External Validation and Head-To-Head Comparison.

Scherdel P, Matczak S, Léger J, Martinez-Vinson C, Goulet O, Brauner R, Nicklaus S, Resche-Rigon M, Chalumeau M, Heude B.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):241-249. doi: 10.1210/jc.2018-00723.

PMID:
30137417
9.

Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients.

Desbois AC, Biard L, Addimanda O, Lambert M, Hachulla E, Launay D, Ackermann F, Pérard L, Hot A, Maurier F, Mausservey C, Bernard F, Noel N, Alric L, Mirault T, Cohen F, Boussouar S, Resche-Rigon M, Cacoub P, Saadoun D.

Clin Immunol. 2018 Dec;197:54-59. doi: 10.1016/j.clim.2018.08.004. Epub 2018 Aug 18.

PMID:
30125675
10.

Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patients.

Mirouse A, Biard L, Comarmond C, Lambert M, Mekinian A, Ferfar Y, Kahn JE, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Cacoub P, Mirault T, Resche-Rigon M, Saadoun D; French Takayasu network.

J Autoimmun. 2019 Jan;96:35-39. doi: 10.1016/j.jaut.2018.08.001. Epub 2018 Aug 17.

PMID:
30122419
11.

Monitoring Personalized Learning Curves for Emergency Ultrasound With Risk-adjusted Learning-curve Cumulative Summation Method.

Peyrony O, Legay L, Morra I, Verrat A, Milacic H, Franchitti J, Amami J, Gillet A, Azarnoush K, Elezi A, Bragança A, Taboulet P, Bourrier P, Fontaine JP, Resche-Rigon M.

AEM Educ Train. 2017 Nov 22;2(1):10-14. doi: 10.1002/aet2.10073. eCollection 2018 Jan.

12.

Dyspnoea in patients receiving noninvasive ventilation for acute respiratory failure: prevalence, risk factors and prognostic impact: A prospective observational study.

Dangers L, Montlahuc C, Kouatchet A, Jaber S, Meziani F, Perbet S, Similowski T, Resche-Rigon M, Azoulay E, Demoule A; REVA Network (Research Network in Mechanical Ventilation) and the Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie (GrrrOH); List of contributors who included study patients: Angers University Hospital, Angers, France:.

Eur Respir J. 2018 Aug 9;52(2). pii: 1702637. doi: 10.1183/13993003.02637-2017. Print 2018 Aug.

PMID:
29976650
13.

Quality of life in cancer patients undergoing anticoagulant treatment with LMWH for venous thromboembolism: the QUAVITEC study on behalf of the Groupe Francophone Thrombose et Cancer (GFTC).

Farge D, Cajfinger F, Falvo N, Berremili T, Couturaud F, Bensaoula O, Védrine L, Bensalha H, Bonnet I, Péré-Vergé D, Coudurier M, Li V, Rafii H, Benzidia I, Connors JM, Resche-Rigon M.

Oncotarget. 2018 Jun 5;9(43):26990-26999. doi: 10.18632/oncotarget.25454. eCollection 2018 Jun 5.

14.

New-onset atrial fibrillation in critically ill patients and its association with mortality: A report from the FROG-ICU study.

Arrigo M, Ishihara S, Feliot E, Rudiger A, Deye N, Cariou A, Guidet B, Jaber S, Leone M, Resche-Rigon M, Vieillard Baron A, Legrand M, Gayat E, Mebazaa A.

Int J Cardiol. 2018 Sep 1;266:95-99. doi: 10.1016/j.ijcard.2018.03.051.

PMID:
29887481
15.

Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis.

Cacoub P, Si Ahmed SN, Ferfar Y, Pol S, Thabut D, Hezode C, Alric L, Comarmond C, Ragab G, Quartuccio L, Hegazy M, Poynard T, Resche Rigon M, Saadoun D.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):518-526. doi: 10.1016/j.cgh.2018.05.021. Epub 2018 May 29.

PMID:
29857143
16.

Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study.

Gauci ML, Boudou P, Baroudjian B, Vidal-Trecan T, Da Meda L, Madelaine-Chambrin I, Basset-Seguin N, Bagot M, Pages C, Mourah S, Resche-Rigon M, Pinel S, Sassier M, Rouby F, Eftekhari P, Lebbé C, Gautier JF.

Cancer Immunol Immunother. 2018 Aug;67(8):1197-1208. doi: 10.1007/s00262-018-2178-0. Epub 2018 May 28.

PMID:
29808365
17.

Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury.

Gayat E, Hollinger A, Cariou A, Deye N, Vieillard-Baron A, Jaber S, Chousterman BG, Lu Q, Laterre PF, Monnet X, Darmon M, Leone M, Guidet B, Sonneville R, Lefrant JY, Fournier MC, Resche-Rigon M, Mebazaa A, Legrand M; FROG-ICU investigators.

Intensive Care Med. 2018 May 15. doi: 10.1007/s00134-018-5160-6. [Epub ahead of print]

PMID:
29766216
18.

Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients.

Mekinian A, Resche-Rigon M, Comarmond C, Soriano A, Constans J, Alric L, Jego P, Busato F, Cabon M, Dhote R, Estibaliz L, Koné-Paut I, Landron C, Lavigne C, Lioger B, Michaud M, Ruivard M, Sacre K, Gottenberg JE, Gaches F, Goulenok T, Salvarani C, Cacoub P, Fain O, Saadoun D; French Takayasu network.

J Autoimmun. 2018 Jul;91:55-60. doi: 10.1016/j.jaut.2018.04.002. Epub 2018 Apr 17.

PMID:
29678346
19.

18FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients.

de Cremoux P, Biard L, Poirot B, Bertheau P, Teixeira L, Lehmann-Che J, Bouhidel FA, Merlet P, Espié M, Resche-Rigon M, Sotiriou C, Groheux D.

Oncotarget. 2018 Mar 27;9(23):16343-16353. doi: 10.18632/oncotarget.24674. eCollection 2018 Mar 27.

20.

Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancer.

Groheux D, Biard L, Lehmann-Che J, Teixeira L, Bouhidel FA, Poirot B, Bertheau P, Merlet P, Espié M, Resche-Rigon M, Sotiriou C, de Cremoux P.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1279-1288. doi: 10.1007/s00259-018-3998-z. Epub 2018 Apr 4.

PMID:
29616304
21.

Emergency Computed Tomography Predicts Caustic Esophageal Stricture Formation.

Bruzzi M, Chirica M, Resche-Rigon M, Corte H, Voron T, Sarfati E, Zagdanski AM, Cattan P.

Ann Surg. 2018 Mar 12. doi: 10.1097/SLA.0000000000002732. [Epub ahead of print]

PMID:
29533267
22.

Endothelial Cell-Specific Molecule-1 in Critically Ill Patients With Hematologic Malignancy.

Zafrani L, Resche-Rigon M, De Freitas Caires N, Gaudet A, Mathieu D, Parmentier-Decrucq E, Lemiale V, Mokart D, Pène F, Kouatchet A, Mayaux J, Vincent F, N'yunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Meert AP, Benoit D, Darmon M, Azoulay E.

Crit Care Med. 2018 Mar;46(3):e250-e257. doi: 10.1097/CCM.0000000000002934.

PMID:
29474336
23.

Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study.

Gayat E, Cariou A, Deye N, Vieillard-Baron A, Jaber S, Damoisel C, Lu Q, Monnet X, Rennuit I, Azoulay E, Léone M, Oueslati H, Guidet B, Friedman D, Tesnière A, Sonneville R, Montravers P, Pili-Floury S, Lefrant JY, Duranteau J, Laterre PF, Brechot N, Chevreul K, Michel M, Cholley B, Legrand M, Launay JM, Vicaut E, Singer M, Resche-Rigon M, Mebazaa A.

Crit Care. 2018 Jan 18;22(1):8. doi: 10.1186/s13054-017-1922-8.

24.

Candiduria in kidney transplant recipients: Is antifungal therapy useful?

Denis B, Chopin D, Piron P, Resche-Rigon M, Bretagne S, Gits-Muselli M, Peraldi MN, Abboud I, Molina JM.

Mycoses. 2018 May;61(5):298-304. doi: 10.1111/myc.12740. Epub 2018 Feb 19.

PMID:
29280198
25.

External validation and comparison of formulae estimating 24-h sodium intake from a fasting morning urine sample.

Vidal-Petiot E, Joseph A, Resche-Rigon M, Boutten A, Mullaert J, d' Ortho MP, Vrtovsnik F, Steg PG, Flamant M.

J Hypertens. 2018 Apr;36(4):785-792. doi: 10.1097/HJH.0000000000001609.

PMID:
29120960
26.

Association of Prognostic Factors and Immunosuppressive Treatment With Long-term Outcomes in Neurosarcoidosis.

Joubert B, Chapelon-Abric C, Biard L, Saadoun D, Demeret S, Dormont D, Resche-Rigon M, Cacoub P.

JAMA Neurol. 2017 Nov 1;74(11):1336-1344. doi: 10.1001/jamaneurol.2017.2492.

27.

Cogan syndrome: Characteristics, outcome and treatment in a French nationwide retrospective study and literature review.

Durtette C, Hachulla E, Resche-Rigon M, Papo T, Zénone T, Lioger B, Deligny C, Lambert M, Landron C, Pouchot J, Kahn JE, Lavigne C, De Wazieres B, Dhote R, Gondran G, Pertuiset E, Quemeneur T, Hamidou M, Sève P, Le Gallou T, Grasland A, Hatron PY, Fain O, Mekinian A; SNFMI and CRI.

Autoimmun Rev. 2017 Dec;16(12):1219-1223. doi: 10.1016/j.autrev.2017.10.005. Epub 2017 Oct 14. Review.

PMID:
29037902
28.

Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study.

Pierrat V, Marchand-Martin L, Arnaud C, Kaminski M, Resche-Rigon M, Lebeaux C, Bodeau-Livinec F, Morgan AS, Goffinet F, Marret S, Ancel PY; EPIPAGE-2 writing group.

BMJ. 2017 Aug 16;358:j3448. doi: 10.1136/bmj.j3448.

29.

The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease.

Legoff J, Resche-Rigon M, Bouquet J, Robin M, Naccache SN, Mercier-Delarue S, Federman S, Samayoa E, Rousseau C, Piron P, Kapel N, Simon F, Socié G, Chiu CY.

Nat Med. 2017 Sep;23(9):1080-1085. doi: 10.1038/nm.4380. Epub 2017 Jul 31.

PMID:
28759053
30.

[Authors'response to the letter on the article "Teledermatology in a prison setting: A retrospective study of 500 expert opinions"].

Khatibi B, Bambe A, Chantalat C, Resche-Rigon M, Sanna A, Fac C, Bagot M, Guibal F.

Ann Dermatol Venereol. 2017 Aug - Sep;144(8-9):544. doi: 10.1016/j.annder.2017.05.003. Epub 2017 Jul 22. French. No abstract available.

PMID:
28739085
31.

Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 Patients.

Comarmond C, Biard L, Lambert M, Mekinian A, Ferfar Y, Kahn JE, Benhamou Y, Chiche L, Koskas F, Cluzel P, Hachulla E, Messas E, Resche-Rigon M, Cacoub P, Mirault T, Saadoun D; French Takayasu Network.

Circulation. 2017 Sep 19;136(12):1114-1122. doi: 10.1161/CIRCULATIONAHA.116.027094. Epub 2017 Jul 12.

PMID:
28701469
32.

Red blood cell transfusion in the resuscitation of septic patients with hematological malignancies.

Mirouse A, Resche-Rigon M, Lemiale V, Mokart D, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Darmon M, Azoulay E, Pène F; Groupe de Recherche sur la Réanimation Respiratoire en Onco-Hématologie (Grrr-OH).

Ann Intensive Care. 2017 Dec;7(1):62. doi: 10.1186/s13613-017-0292-3. Epub 2017 Jun 12.

33.

Propensity score analysis with partially observed covariates: How should multiple imputation be used?

Leyrat C, Seaman SR, White IR, Douglas I, Smeeth L, Kim J, Resche-Rigon M, Carpenter JR, Williamson EJ.

Stat Methods Med Res. 2019 Jan;28(1):3-19. doi: 10.1177/0962280217713032. Epub 2017 Jun 2.

34.

Grade Group Underestimation in Prostate Biopsy: Predictive Factors and Outcomes in Candidates for Active Surveillance.

Audenet F, Rozet F, Resche-Rigon M, Bernard R, Ingels A, Prapotnich D, Sanchez-Salas R, Galiano M, Barret E, Cathelineau X.

Clin Genitourin Cancer. 2017 Dec;15(6):e907-e913. doi: 10.1016/j.clgc.2017.04.024. Epub 2017 Apr 26.

PMID:
28522288
35.

In Response to "Hypothermia for Neuroprotection in Convulsive Status Epilepticus".

Legriel S, Resche-Rigon M, Cariou A.

J Emerg Med. 2017 Jul;53(1):140-141. doi: 10.1016/j.jemermed.2017.03.029. Epub 2017 May 8. No abstract available.

PMID:
28495123
36.

Ustekinumab for Behçet's disease.

Mirouse A, Barete S, Monfort JB, Resche-Rigon M, Bouyer AS, Comarmond C, Sène D, Domont F, Ferfar Y, Cacoub P, Saadoun D.

J Autoimmun. 2017 Aug;82:41-46. doi: 10.1016/j.jaut.2017.05.002. Epub 2017 May 5.

PMID:
28483439
37.

Gastrointestinal emergencies in critically ill cancer patients.

Lebon D, Biard L, Buyse S, Schnell D, Lengliné E, Roussel C, Gornet JM, Munoz-Bongrand N, Quéro L, Resche-Rigon M, Azoulay E, Canet E.

J Crit Care. 2017 Aug;40:69-75. doi: 10.1016/j.jcrc.2017.03.015. Epub 2017 Mar 24.

PMID:
28363097
38.

Hypothermia for Convulsive Status Epilepticus.

Legriel S, Resche-Rigon M, Cariou A.

N Engl J Med. 2017 Mar 16;376(11):1095-6. doi: 10.1056/NEJMc1700535. No abstract available.

PMID:
28296616
39.

Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.

Saadoun D, Pol S, Ferfar Y, Alric L, Hezode C, Si Ahmed SN, de Saint Martin L, Comarmond C, Bouyer AS, Musset L, Poynard T, Resche Rigon M, Cacoub P.

Gastroenterology. 2017 Jul;153(1):49-52.e5. doi: 10.1053/j.gastro.2017.03.006. Epub 2017 Mar 10.

40.

Targeted temperature management after intraoperative cardiac arrest: a multicenter retrospective study.

Constant AL, Mongardon N, Morelot Q, Pichon N, Grimaldi D, Bordenave L, Soummer A, Sauneuf B, Merceron S, Ricome S, Misset B, Bruel C, Schnell D, Boisramé-Helms J, Dubuisson E, Brunet J, Lasocki S, Cronier P, Bouhemad B, Carreira S, Begot E, Vandenbunder B, Dhonneur G, Jullien P, Resche-Rigon M, Bedos JP, Montlahuc C, Legriel S.

Intensive Care Med. 2017 Apr;43(4):485-495. doi: 10.1007/s00134-017-4709-0. Epub 2017 Feb 20.

PMID:
28220232
41.

[Evaluation of a new information tool in an Emergency Department]

Pouessel A, Chauvin A, Truchot J, Resche-Rigon M, Galichon B, Plaisance P.

Rech Soins Infirm. 2016 Sep;(126):93-106. French.

PMID:
28169817
42.

Hypothermia for Neuroprotection in Convulsive Status Epilepticus.

Legriel S, Lemiale V, Schenck M, Chelly J, Laurent V, Daviaud F, Srairi M, Hamdi A, Geri G, Rossignol T, Hilly-Ginoux J, Boisramé-Helms J, Louart B, Malissin I, Mongardon N, Planquette B, Thirion M, Merceron S, Canet E, Pico F, Tran-Dinh YR, Bedos JP, Azoulay E, Resche-Rigon M, Cariou A; HYBERNATUS Study Group.

N Engl J Med. 2016 Dec 22;375(25):2457-2467. doi: 10.1056/NEJMoa1608193.

43.

Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study.

Contejean A, Lemiale V, Resche-Rigon M, Mokart D, Pène F, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Perez P, Meert AP, Benoit D, Hamidfar R, Darmon M, Jourdain M, Renault A, Schlemmer B, Azoulay E.

Ann Intensive Care. 2016 Dec;6(1):102. doi: 10.1186/s13613-016-0202-0. Epub 2016 Oct 25.

44.

MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C.

Appourchaux K, Dokmak S, Resche-Rigon M, Treton X, Lapalus M, Gattolliat CH, Porchet E, Martinot-Peignoux M, Boyer N, Vidaud M, Bedossa P, Marcellin P, Bièche I, Estrabaud E, Asselah T.

Sci Rep. 2016 Oct 12;6:34935. doi: 10.1038/srep34935.

45.

High-Flow Nasal Cannula Oxygenation in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study.

Lemiale V, Resche-Rigon M, Mokart D, Pène F, Argaud L, Mayaux J, Guitton C, Rabbat A, Girault C, Kouatchet A, Vincent F, Bruneel F, Nyunga M, Seguin A, Klouche K, Colin G, Kontar L, Perez P, Meert AP, Benoit DD, Papazian L, Demoule A, Chevret S, Azoulay E.

Crit Care Med. 2017 Mar;45(3):e274-e280. doi: 10.1097/CCM.0000000000002085.

PMID:
27655324
46.

Multiple imputation by chained equations for systematically and sporadically missing multilevel data.

Resche-Rigon M, White IR.

Stat Methods Med Res. 2018 Jun;27(6):1634-1649. doi: 10.1177/0962280216666564. Epub 2016 Sep 19.

47.

Neuroprotective effect of therapeutic hypothermia versus standard care alone after convulsive status epilepticus: protocol of the multicentre randomised controlled trial HYBERNATUS.

Legriel S, Pico F, Tran-Dinh YR, Lemiale V, Bedos JP, Resche-Rigon M, Cariou A.

Ann Intensive Care. 2016 Dec;6(1):54. doi: 10.1186/s13613-016-0159-z. Epub 2016 Jun 21. Review.

48.

Automated quantification of Epstein-Barr Virus in whole blood of hematopoietic stem cell transplant patients using the Abbott m2000 system.

Salmona M, Fourati S, Feghoul L, Scieux C, Thiriez A, Simon F, Resche-Rigon M, LeGoff J.

Diagn Microbiol Infect Dis. 2016 Aug;85(4):428-32. doi: 10.1016/j.diagmicrobio.2016.04.017. Epub 2016 Apr 28.

PMID:
27312691
49.

Usefulness of daily surveillance blood cultures in allogeneic hematopoietic stem cell transplant recipients on steroids: a 1-year prospective study.

Colombier MA, Lafaurie M, de Fontbrune FS, Resche-Rigon M, Donay JL, Pons JL, Molina JM, Socie G.

Transpl Infect Dis. 2016 Aug;18(4):504-11. doi: 10.1111/tid.12552. Epub 2016 Aug 1.

PMID:
27218243
50.

Investigating covariate-by-centre interaction in survival data.

Biard L, Labopin M, Chevret S, Resche-Rigon M; Acute Leukaemia Working Party of the EBMT.

Stat Methods Med Res. 2018 Mar;27(3):920-932. doi: 10.1177/0962280216647981. Epub 2016 May 10.

PMID:
27166409

Supplemental Content

Loading ...
Support Center